-
Biohaven Acquires Kleo Pharmaceuticals
Post on 1/7/21
-
Werewolf Therapeutics Completes $72 Million Series B Financing
Post on 1/7/21
-
Alira Health Acquires Chamow and Associates
Post on 1/7/21
-
LifeMine Therapeutics Raises $50 Million Series B
Post on 1/7/21
-
Scorpion Therapeutics Raises $162M In Series B
Post on 1/7/21
-
Berkshire Hathaway Q4 2020 Earnings And Book Value Estimates
Post on 1/7/21
-
bluebird bio Inc., Undervalued Acquisition Candidate
Post on 1/7/21
-
Moderna Coronavirus Vaccine Approved in Europe
Post on 1/7/21
-
Generation Bio Prices of Public Offering
Post on 1/7/21
-
Chiasma Provides Corporate Update
Post on 1/6/21
-
Aileron Therapeutics Announces $35.9 Million Registered Direct Offering
Post on 1/6/21
-
Radius Health Acquires Orphan Disease Program
Post on 1/6/21
-
EyeGate Enters Into Agreement for $8.0 Million Private Placement
Post on 1/6/21
-
FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply
Post on 1/6/21
-
Provident Healthcare Partners Advises Companion Hospice In Its Acquisition By Bristol Hospice
Post on 1/5/21
-
Blue Earth Diagnostics Acquires Worldwide Rights to Therapeutic Applications of Scintomics rhPSMA
Post on 1/5/21
-
Rhythm Pharmaceuticals Sale of Priority Review Voucher for $100M
Post on 1/5/21
-
The Worst Mistake Moderna Investors Can Make Right Now
Post on 1/5/21
-
Moderna Lifts Its Estimate for 2021 Coronavirus Vaccine Production by 20%
Post on 1/5/21
-
Charles River Laboratories Acquires Distributed Bio
Post on 1/4/21
-
Boston Scientific Corporation: Buy This Secular Grower As Elective Procedures Rebound
Post on 1/4/21
-
Why Moderna Stock Fell 32% in December
Post on 1/4/21
-
EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics
Post on 1/3/21
-
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
Post on 12/23/20
-
Sale of Kantar Health Kicks Off Bain Makeover
Post on 12/23/20
Boston
